TL;DR: Algen Biotechnologies is a Y Combinator Winter 2020 startup Using CRISPR to find treatments for cancer and inflammation, currently active with a team of 15.
Using CRISPR to find treatments for cancer and inflammation
Last verified:
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.
Built by LemStudio
Yes. Algen Biotechnologies was funded by Y Combinator in the Winter 2020 batch. Using CRISPR to find treatments for cancer and inflammation
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer fr…
Algen Biotechnologies was part of Y Combinator's Winter 2020 batch.
Algen Biotechnologies has a team of 15 people according to Y Combinator's directory.
Algen Biotechnologies is currently listed as Active with a team of 15 in Y Combinator's directory.
Loading interactive view…